Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Puma Biotechnology, Inc. , a biopharmaceutical company, announced the initiation of its ALISertib in CAncer (ALISCA-Lung1) Phase II trial (PUMA-ALI-4201; NCT06095505) of alisertib monotherapy for the treatment of patients with extensive stage small.
Puma Biotechnology, Inc. (NASDAQ:PBYI – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.52 and traded as high as $5.16. Puma Biotechnology shares last traded at $4.71, with a volume of 749,465 shares trading hands. Wall Street Analyst Weigh In Separately, […]
Puma Biotechnology, Inc. , a biopharmaceutical company , announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company on.
Puma Biotechnology to Present at B Riley Securities 4th Annual Oncology Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.